|Podcasts|September 15, 2011
INC's CEO Discusses the Current CRO Climate
Jim Ogle, CEO of INC Research, offers his take on industry consolidation, what it means for the future, and INC's own role and strategy in its recent acquisitions.
Advertisement
INC’s CEO Discusses the Current CRO Climate
Jim Ogle, CEO of INC Research, offers his take on industry consolidation, what it means for the future, and INC’s own role and strategy in its recent acquisitions.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves UCB’s Kygevi for TK2 Deficiency Based on Multi-Study Clinical Program Demonstrating Significant Survival and Motor Gains
2
Inside the Recruitment Bottlenecks Driving Trial Delays
3
Takeda’s Phase III TIDES Trial Confirms Long-Term Efficacy and Safety of Qdenga Dengue Vaccine
4
ACT Brief: Tech-Driven Data Strategies and Long-Term Vaccine Success
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
